Cyclical edema in a patient with hypothalamic disorders and chronic glomerulonephritis: arginine vasopressin-dependent atrial natriuretic hormone release.
A 28-year-old woman had hypothalamic disorders (amenorrhea, obesity, psychiatric abnormalities, polydipsia and fever) and chronic glomerulonephritis. She also suffered from general edema associated with cyclical oliguria and polyuria. Her body weight and plasma osmolality increased during the oliguria phase lasting 2 to 8 days and decreased after paroxysmal polyuria accompanied by the natriuresis. These episodes occurred repeatedly, regardless of the treatment with or without diuretics. The release of arginine vasopressin in response to increased plasma osmolality was exaggerated, but changes in plasma volume did not affect arginine vasopressin release. Plasma atrial natriuretic hormone increased in response to a rise in plasma arginine vasopressin and plasma volume during the oliguria phase, thereby resulting in the diuresis and natriuresis. The renin-angiotensin-aldosterone system was secondarily activated by body fluid depletion and diuretics, and this might play an additive role in general swelling. Plasma gonadal hormones did not change to explain the edema. The mechanism of this cyclical edema remains unknown, but it is likely that hypothalamic dysfunction related to psychiatric abnormalities may exaggerate arginine vasopressin release, and enhanced renal sympathetic activity may cause retention of Na and water, and the increase in atrial natriuretic hormone release responding to the plasma volume expansion may bring about the diuresis and natriuresis.
Yamamoto
T
T
Second Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.
Kimura
T
T
Ota
K
K
Shoji
M
M
Inoue
M
M
Sato
K
K
Ohta
M
M
Saito
T
T
Abe
K
K
Yoshinaga
K
K
D000328:Adult; D000450:Aldosterone / Q000652:urine; D001127:Arginine Vasopressin; D009320:Atrial Natriuretic Factor / Q000378:metabolism*; D001835:Body Weight; D002908:Chronic Disease; D004487:Edema / Q000209:etiology* / Q000378:metabolism; D005260:Female; D005640:Follicle Stimulating Hormone / Q000652:urine; D005921:Glomerulonephritis / Q000150:complications*; D013006:Growth Hormone / Q000652:urine; D006801:Humans; D006854:Hydrocortisone / Q000652:urine; D007027:Hypothalamic Diseases / Q000150:complications*; D007986:Luteinizing Hormone / Q000652:urine; D009846:Oliguria; D009994:Osmolar Concentration; D010949:Plasma / Q000737:chemistry; D011141:Polyuria; D011388:Prolactin / Q000652:urine; D013972:Thyrotropin / Q000652:urine; D013974:Thyroxine / Q000494:pharmacology; D014882:Water-Electrolyte Balance
D001127:Arginine Vasopressin; D000450:Aldosterone; D009320:Atrial Natriuretic Factor; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013972:Thyrotropin; D013006:Growth Hormone; D013974:Thyroxine; D006854:Hydrocortisone